Viriom

Quick facts

Phase 3 pipeline

• AV5080 · Infectious Disease / Virology
  AV5080 is a nucleoside analog that inhibits viral RNA-dependent RNA polymerase, blocking replication of RNA viruses.

Phase 2 pipeline

• VM-1500
• VM-1500A-LAI

Phase 1 pipeline

• Elpida®
• VM-1500FDC

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Viriom portfolio CI brief
• Viriom pipeline updates RSS